Long-chain omega-3 fatty acids: Time to establish a dietary reference intake

Michael R. Flock, William S. Harris, Penny Margaret Kris-Etherton

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

The beneficial effects of consuming omega-3 polyunsaturated fatty acids (n-3 PUFAs), specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), on cardiovascular health have been studied extensively. To date, there is no dietary reference intake (DRI) for EPA and DHA, although many international authorities and expert groups have issued dietary recommendations for them. Given the substantial new evidence published since the last Institute of Medicine (IOM) report on energy and macronutrients, released in 2002, there is a pressing need to establish a DRI for EPA and DHA. In order to set a DRI, however, more information is needed to define the intakes of EPA and DHA required to reduce the burden of chronic disease. Information about potential gender- or race-based differences in requirements is also needed. Given the many health benefits of EPA and DHA that have been described since the 2002 IOM report, there is now a strong justification for establishing a DRI for these fatty acids.

Original languageEnglish (US)
Pages (from-to)692-707
Number of pages16
JournalNutrition Reviews
Volume71
Issue number10
DOIs
StatePublished - Oct 1 2013

Fingerprint

Recommended Dietary Allowances
Eicosapentaenoic Acid
Docosahexaenoic Acids
Omega-3 Fatty Acids
National Academies of Science, Engineering, and Medicine (U.S.) Health and Medicine Division
Insurance Benefits
Unsaturated Fatty Acids
Chronic Disease
Fatty Acids
Health

All Science Journal Classification (ASJC) codes

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Flock, Michael R. ; Harris, William S. ; Kris-Etherton, Penny Margaret. / Long-chain omega-3 fatty acids : Time to establish a dietary reference intake. In: Nutrition Reviews. 2013 ; Vol. 71, No. 10. pp. 692-707.
@article{4227205d1a014d0ea960f420ffe25b1d,
title = "Long-chain omega-3 fatty acids: Time to establish a dietary reference intake",
abstract = "The beneficial effects of consuming omega-3 polyunsaturated fatty acids (n-3 PUFAs), specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), on cardiovascular health have been studied extensively. To date, there is no dietary reference intake (DRI) for EPA and DHA, although many international authorities and expert groups have issued dietary recommendations for them. Given the substantial new evidence published since the last Institute of Medicine (IOM) report on energy and macronutrients, released in 2002, there is a pressing need to establish a DRI for EPA and DHA. In order to set a DRI, however, more information is needed to define the intakes of EPA and DHA required to reduce the burden of chronic disease. Information about potential gender- or race-based differences in requirements is also needed. Given the many health benefits of EPA and DHA that have been described since the 2002 IOM report, there is now a strong justification for establishing a DRI for these fatty acids.",
author = "Flock, {Michael R.} and Harris, {William S.} and Kris-Etherton, {Penny Margaret}",
year = "2013",
month = "10",
day = "1",
doi = "10.1111/nure.12071",
language = "English (US)",
volume = "71",
pages = "692--707",
journal = "Nutrition Reviews",
issn = "0029-6643",
publisher = "Wiley-Blackwell",
number = "10",

}

Long-chain omega-3 fatty acids : Time to establish a dietary reference intake. / Flock, Michael R.; Harris, William S.; Kris-Etherton, Penny Margaret.

In: Nutrition Reviews, Vol. 71, No. 10, 01.10.2013, p. 692-707.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Long-chain omega-3 fatty acids

T2 - Time to establish a dietary reference intake

AU - Flock, Michael R.

AU - Harris, William S.

AU - Kris-Etherton, Penny Margaret

PY - 2013/10/1

Y1 - 2013/10/1

N2 - The beneficial effects of consuming omega-3 polyunsaturated fatty acids (n-3 PUFAs), specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), on cardiovascular health have been studied extensively. To date, there is no dietary reference intake (DRI) for EPA and DHA, although many international authorities and expert groups have issued dietary recommendations for them. Given the substantial new evidence published since the last Institute of Medicine (IOM) report on energy and macronutrients, released in 2002, there is a pressing need to establish a DRI for EPA and DHA. In order to set a DRI, however, more information is needed to define the intakes of EPA and DHA required to reduce the burden of chronic disease. Information about potential gender- or race-based differences in requirements is also needed. Given the many health benefits of EPA and DHA that have been described since the 2002 IOM report, there is now a strong justification for establishing a DRI for these fatty acids.

AB - The beneficial effects of consuming omega-3 polyunsaturated fatty acids (n-3 PUFAs), specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), on cardiovascular health have been studied extensively. To date, there is no dietary reference intake (DRI) for EPA and DHA, although many international authorities and expert groups have issued dietary recommendations for them. Given the substantial new evidence published since the last Institute of Medicine (IOM) report on energy and macronutrients, released in 2002, there is a pressing need to establish a DRI for EPA and DHA. In order to set a DRI, however, more information is needed to define the intakes of EPA and DHA required to reduce the burden of chronic disease. Information about potential gender- or race-based differences in requirements is also needed. Given the many health benefits of EPA and DHA that have been described since the 2002 IOM report, there is now a strong justification for establishing a DRI for these fatty acids.

UR - http://www.scopus.com/inward/record.url?scp=84885468015&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885468015&partnerID=8YFLogxK

U2 - 10.1111/nure.12071

DO - 10.1111/nure.12071

M3 - Article

C2 - 24117792

AN - SCOPUS:84885468015

VL - 71

SP - 692

EP - 707

JO - Nutrition Reviews

JF - Nutrition Reviews

SN - 0029-6643

IS - 10

ER -